- Clinical Essentials from JAMA Cardiol
- 1 comment
Which image modality is best for diagnosing myocardial ischemia?
CT and PET best SPECT and hybrid approaches.
Recommended in Radiology
- JAMA Oncology
- 1 comment
Study suggests, aggressive yet safe treatment for patients with intrahepatic cancer and at high risk for liver damage
- JAMA Oncology
- 1 comment
Intensive cancer surveillance protocol for individuals with pathogenic germline TP53 variants
- Univadis Medical News
- no comment
Brexit threatens supply of medical isotope cancer therapies
- Univadis Medical News
- 1 comment
EMA suspends authorisation for 3 MRI contrast agents
- Univadis Medical News
- 1 comment
Brain damage reversed in a drowned toddler
- Univadis Medical News
- 1 comment
Responding to terror attacks: training manual being developed for doctors in Europe
- Univadis Medical News
- 1 comment
Are you meeting stethoscope hygiene standards?
- Univadis Medical News
- 1 comment
Watchdog opens investigation into European Medicines Agency
Professional & Business
- International Medical Press
Calorie reduction next step in childhood obesity plan
- International Medical Press
Third of trainee GPs plan to leave NHS within 6 months
- International Medical Press
Proposed cuts to sexual health services deemed ‘unsafe’
- International Medical Press
Government to cover rising GP indemnity fees
- International Medical Press
Type 2 diabetes in children on the rise
- International Medical Press
UKSTSG training report gets mixed response
New in Radiology
- Clinical Essentials from BJU Int
- no comment
mpMRI tops biopsy for identifying aggressive apical prostate cancer
MRI can be useful for planning the extent of apical preservation during prostatectomy
- Univadis Medical News
- 1 comment
Patient participation in hand hygiene initiatives should not be seen as a threat
Almost half of physicians feel patients should not be offering reminders to perform hand hygiene.
- Univadis Medical News
- 1 comment
UK has witnessed a marked decline in colorectal cancer deaths
Trend attributed to screening programmes and better treatments.
- Clinical Essentials from J Crit Care
- 1 comment
Zika infection can cause life-threatening neurologic disease in adults
Although most cases are mild, some can lead to Guillain-Barré syndrome and encephalitis.
- Clinical Essentials from Laryngoscope
- 1 comment
Oropharyngeal cancer: TORS best without adjuvant therapy
Adjuvant therapy lowers QoL without improving clinical outcome.
- Clinical Essentials from MMWR Morb Mortal Wkly Rep
- 1 comment
- FULLTEXT
Pediatric paralysis mystifies CDC
No cause identified for a cluster of acute flaccid paralysis in Washington State.
- Clinical Essentials from JAMA Neurol
- 1 comment
Triggers, risk factors for recrudescence of stroke deficits identified
Infection, hypotension, and stress are among the possible triggers.
- Clinical Essentials from Eur J Cancer
- 1 comment
Nonsmoker lung cancer on the rise in UK
Number of cases in never-smokers more than doubled between 2008 and 2014.
- Clinical Essentials from J Transl Med
- 1 comment
- FULLTEXT
HNSCC: neutrophil count predicts post-RT survival
A higher baseline neutrophil count correlates with poor OS, CSS and DC.
- Clinical Essentials from Radiother Oncol
- 1 comment
HNSCC: is upfront dissection before RT beneficial?
The benefits of upfront ND in patients with HNSCC are controversial.
- Monthly Essentials
- 1 comment
Neurological Disorders: Monthly Essentials August 2017
FDA approves newborn MRI device | Creatine disappoints in Huntington's | Ataluren bests placebo in some DMD | NOACs vs VKAs in real-world Afib.
- Clinical Essentials from JAMA
- 1 comment
In SAVR, cerebral embolic protection devices don't live up to their name
No reduced risk for cerebral infarction vs using a standard aortic cannula in short term.
- Clinical Essentials from World Neurosurg
- 1 comment
Traumatic brain injury: predictors of "talk and die" identified
Data from a multicenter study of more than 24K patients.
- Clinical Essentials from Lancet Oncol
- 1 comment
- FULLTEXT
CRC with liver mets: SIRT fails to add OS benefit to first-line FOLFOX
A combined analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global phase 3 trials.